Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 2/20 | 0.55 |
| ▸ | PPIA | P62937 | 7/20 | 0.47 |
| ▸ | PPIF | P30405 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9126321 | 0.94 | SGMS2 (0.50) | SGMS2PPIAPPIFKMT2ATDP1 | |
| SCHEMBL9124294 | 0.93 | PPIA (0.50) | SGMS2PPIAPPIFKMT2ATDP1 | |
| SCHEMBL9126866 | 0.92 | PPIA (0.52) | SGMS2PPIAKMT2AALDH1A1MAPT | |
| SCHEMBL9125275 | 0.91 | PPIF (0.49) | SGMS2PPIAPPIFKMT2ATDP1 | |
| SCHEMBL9123738 | 0.89 | PPIF (0.55) | SGMS2PPIAPPIFKMT2ATDP1 | |
| SCHEMBL9126729 | 0.87 | SGMS2 (0.55) | SGMS2PPIAPPIFTDP1DHODH | |
| SCHEMBL9125551 | 0.87 | PPIA (0.53) | SGMS2PPIAPPIFKMT2AALDH1A1 | |
| SCHEMBL9124509 | 0.86 | PPIA (0.53) | SGMS2PPIAPPIFKMT2ATDP1 | |
| SCHEMBL9124740 | 0.84 | PPIA (0.55) | SGMS2PPIAKMT2AALDH1A1MAPT | |
| SCHEMBL9126812 | 0.82 | PPIA (0.52) | PPIAPPIFKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5409943-A | [(alkoxy)pyridinyl]amine compounds which are useful in the treatment of gastrointestinal disorders | SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) | 1995-04-25 | — | — | US | disclosed |